chitosan has been researched along with Group A Strep Infection in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (13.33) | 29.6817 |
2010's | 10 (66.67) | 24.3611 |
2020's | 3 (20.00) | 2.80 |
Authors | Studies |
---|---|
Dar, SA; Jeong, HJ; Jung, SJ; Kole, S; Shin, SM | 1 |
Dechbumroong, P; Kamble, MT; Keaswejjareansuk, W; Kitiyodom, S; Namdee, K; Pirarat, N; Rodkhum, C; Suwanbumrung, D; Thompson, KD; Wongkhieo, S; Yata, T | 1 |
Capon, RJ; Hussein, WM; Khalil, ZG; Nahar, UJ; Skwarczynski, M; Toth, I; Yang, J; Zhao, L | 1 |
Hao, L; Ke, H; Liang, ZL; Liu, ZX; Ma, JY; Ma, YP | 1 |
Chen, D; Geng, Y; He, J; He, Y; Huang, X; Lai, W; Ouyang, P; Wang, E; Wang, K; Wang, X; Zhu, L | 1 |
Batzloff, MR; Capon, RJ; Good, MF; Hussein, WM; Khalil, ZG; Nevagi, RJ; Powell, J; Skwarczynski, M; Toth, I | 1 |
Abbaspour, MR; Alishahi, M; Ghorbanpoor, M; Halimi, M; Tabandeh, MR | 1 |
Campos, DA; Cardelle-Cobas, A; Costa, EM; Costa, MR; Madureira, AR; Odila, J; Pereira, M; Pintado, MM; Rodrigues, AS; Silva, S; Tavaria, FK | 1 |
Bonferoni, MC; Boselli, C; Caramella, C; Cornaglia, AI; Daglia, M; Ferrari, F; Marchese, A; Mentori, I; Rossi, S; Sandri, G; Tenci, M | 1 |
Batzloff, MR; Capon, RJ; Giddam, AK; Good, MF; Hussein, WM; Khalil, ZG; Marasini, N; Skwarczynski, M; Toth, I | 1 |
Almeida, AJ; Alpar, HO; Florindo, HF; Gonçalves, LM; Pandit, S | 1 |
Fan, H; Gao, GF; Li, X; Lu, C; Xu, Y | 1 |
Almeida, AJ; Cadete, A; Figueiredo, L; Florindo, HF; Gomes de Azevedo, E; Gonçalves, LM; Matos, HA; Padrela, L; Rodrigues, MA; Tiago, J | 1 |
Hirnle, L; Hirnle, P; Kubis, AA; Małolepsza-Jarmołowska, K | 1 |
Chen, Q; Fu, ML; Gao, R; Li, JL; Lv, XB; Peng, R; Wang, HN; Wang, YY; Wang, ZZ; Wu, KY; Xie, Z; Zhao, ZZ | 1 |
2 trial(s) available for chitosan and Group A Strep Infection
Article | Year |
---|---|
Potential Efficacy of Chitosan-Poly (Lactide-Co-Glycolide)-Encapsulated Trivalent Immersion Vaccine in Olive Flounder (
Topics: Animals; Antigens, Viral; Chitosan; Ciliophora Infections; Complement C3; Cytokines; Fish Diseases; Flounder; Gene Expression; Hemorrhagic Septicemia, Viral; Immunoglobulins; Kidney; Oligohymenophorea; Polylactic Acid-Polyglycolic Acid Copolymer; Spleen; Streptococcal Infections; Streptococcus; Toll-Like Receptors; Treatment Outcome; Viral Vaccines | 2021 |
Preparation, characterization and evaluation of the immune effect of alginate/chitosan composite microspheres encapsulating recombinant protein of Streptococcus iniae designed for fish oral vaccination.
Topics: Alginates; Animals; Bacterial Proteins; Bacterial Vaccines; Chitosan; Fish Diseases; Glucuronic Acid; Hexuronic Acids; Ictaluridae; Immunity, Innate; Microspheres; Recombinant Proteins; Streptococcal Infections; Streptococcus iniae; Vaccination | 2018 |
13 other study(ies) available for chitosan and Group A Strep Infection
Article | Year |
---|---|
Oral delivery of a Streptococcus agalactiae vaccine to Nile tilapia (Oreochromis niloticus) using a novel cationic-based nanoemulsion containing bile salts.
Topics: Animals; Bacterial Vaccines; Chitosan; Cichlids; Fish Diseases; Streptococcal Infections; Streptococcus agalactiae; Tilapia | 2023 |
A dual-adjuvanting strategy for peptide-based subunit vaccines against group A Streptococcus: Lipidation and polyelectrolyte complexes.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies; Cell Line; Cell Survival; Chitosan; Chromobox Protein Homolog 5; Female; Humans; Immunity, Humoral; Lipopeptides; Mice; Nanoparticles; Polyelectrolytes; Polyglutamic Acid; Streptococcal Infections; Streptococcus pyogenes; Vaccines, Subunit | 2020 |
Protective efficacy of cationic-PLGA microspheres loaded with DNA vaccine encoding the sip gene of Streptococcus agalactiae in tilapia.
Topics: Animals; Bacterial Vaccines; Chitosan; Fish Diseases; Genes, Bacterial; Immunity, Innate; Immunogenicity, Vaccine; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Random Allocation; Streptococcal Infections; Streptococcus agalactiae; Tilapia; Tissue Distribution; Vaccines, DNA | 2017 |
Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus.
Topics: Administration, Intranasal; Animals; Antibodies, Bacterial; Antibody Formation; Cell Differentiation; Chitosan; Dendritic Cells; Immunity; Macrophages; Mice, Inbred C57BL; Nanoparticles; Opsonin Proteins; Polyglutamic Acid; Streptococcal Infections; Streptococcus pyogenes; Vaccines, Subunit | 2018 |
Valuable method for production of oral vaccine by using alginate and chitosan against Lactococcus garvieae/Streptococcus iniae in rainbow trout (Oncorhynchus mykiss).
Topics: Administration, Oral; Alginates; Animals; Bacterial Vaccines; Chitosan; Fish Diseases; Gram-Positive Bacterial Infections; Lactococcus; Oncorhynchus mykiss; Streptococcal Infections; Streptococcal Vaccines; Streptococcus iniae | 2019 |
Chitosan mouthwash: toxicity and in vivo validation.
Topics: Animals; Anti-Infective Agents, Local; Cell Line; Chitosan; Chromosome Aberrations; Cricetulus; Enterococcus; Humans; Microbial Sensitivity Tests; Mouthwashes; Mutagenicity Tests; Streptococcal Infections; Streptococcus | 2014 |
Application of DoE approach in the development of mini-capsules, based on biopolymers and manuka honey polar fraction, as powder formulation for the treatment of skin ulcers.
Topics: Animals; Anti-Bacterial Agents; Biopolymers; Capsules; Chemistry, Pharmaceutical; Chitosan; Fibroblasts; Glutamic Acid; Honey; Humans; Hyaluronic Acid; Male; Pectins; Powders; Rats; Rats, Wistar; Skin Ulcer; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Wound Healing | 2017 |
Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Cells, Cultured; Chitosan; Dendritic Cells; Dextrans; Drug Delivery Systems; Female; Lipopeptides; Mice; Nanoparticles; Streptococcal Infections; Streptococcal Vaccines; Streptococcus pyogenes | 2016 |
Surface modified polymeric nanoparticles for immunisation against equine strangles.
Topics: Adsorption; Alginates; Animals; Bacterial Proteins; Buffers; Cell Wall; Chitosan; Delayed-Action Preparations; Glucuronic Acid; Hexuronic Acids; Horses; Lactic Acid; Magnetic Resonance Spectroscopy; Nanoparticles; Particle Size; Polyesters; Polymers; Polyvinyl Alcohol; Respiratory Tract Infections; Solvents; Static Electricity; Streptococcal Infections; Streptococcal Vaccines; Streptococcus equi | 2010 |
Synthesis of galabiose-chitosan conjugate as potent inhibitor of Streptococcus suis adhesion.
Topics: Aldehydes; Amines; Anti-Bacterial Agents; Bacterial Adhesion; Chitosan; Disaccharides; Erythrocytes; Humans; Molecular Structure; Streptococcal Infections; Streptococcus suis | 2010 |
Development of a novel mucosal vaccine against strangles by supercritical enhanced atomization spray-drying of Streptococcus equi extracts and evaluation in a mouse model.
Topics: Animals; Antibodies, Bacterial; Antigens, Bacterial; Chitosan; Equidae; Female; Horse Diseases; Horses; Immunoglobulin G; Kinetics; Mice; Mice, Inbred BALB C; Nanospheres; Solutions; Streptococcal Infections; Streptococcal Vaccines; Streptococcus equi; Th1 Cells; Th2 Cells; Vaccination; Water | 2012 |
[Acute, hemorrhagic, overgrowing vaginal inflammation caused by Streptococcus agalacitae--case study].
Topics: Acute Disease; Administration, Intravaginal; Anti-Bacterial Agents; Chitosan; Female; Humans; Inflammation; Lactic Acid; Middle Aged; Streptococcal Infections; Streptococcus agalactiae; Treatment Outcome; Vaginal Discharge; Vaginosis, Bacterial | 2006 |
Enhancement of immunity and resistance in mice by pig IL-6 gene and CpG motifs encapsulated in chitosan nanoparticle.
Topics: Adjuvants, Immunologic; Animals; Chitosan; CpG Islands; Enzyme-Linked Immunosorbent Assay; Immunity, Innate; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Interleukin-2; Interleukin-4; Interleukin-6; Mice; Nanoparticles; Oligodeoxyribonucleotides; Plasmids; Streptococcal Infections; Streptococcus suis; Swine; Time Factors; Virulence | 2008 |